Cargando…
Production of an Active, Human Membrane Protein in Saccharomyces cerevisiae: Full-Length FICD
The human Fic domain-containing protein (FICD) is a type II endoplasmic reticulum (ER) membrane protein that is important for the maintenance of ER proteostasis. Structural and in vitro biochemical characterisation of FICD AMPylase and deAMPylase activity have been restricted to the soluble ER-lumin...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910494/ https://www.ncbi.nlm.nih.gov/pubmed/35269596 http://dx.doi.org/10.3390/ijms23052458 |
_version_ | 1784666497352728576 |
---|---|
author | Virolainen, Minttu S. Søltoft, Cecilie L. Pedersen, Per A. Ellgaard, Lars |
author_facet | Virolainen, Minttu S. Søltoft, Cecilie L. Pedersen, Per A. Ellgaard, Lars |
author_sort | Virolainen, Minttu S. |
collection | PubMed |
description | The human Fic domain-containing protein (FICD) is a type II endoplasmic reticulum (ER) membrane protein that is important for the maintenance of ER proteostasis. Structural and in vitro biochemical characterisation of FICD AMPylase and deAMPylase activity have been restricted to the soluble ER-luminal domain produced in Escherichia coli. Information about potentially important features, such as structural motifs, modulator binding sites or other regulatory elements, is therefore missing for the approximately 100 N-terminal residues including the transmembrane region of FICD. Expressing and purifying the required quantity and quality of membrane proteins is demanding because of the low yields and poor stability often observed. Here, we produce full-length FICD by combining a Saccharomyces cerevisiae-based platform with green fluorescent protein (GFP) tagging to optimise the conditions for expression, solubilisation and purification. We subsequently employ these conditions to purify milligram quantities of His-tagged FICD per litre of culture, and show that the purified, detergent-solubilised membrane protein is an active deAMPylating enzyme. Our work provides a straightforward methodology for producing not only full-length FICD, but also other membrane proteins in S. cerevisiae for structural and biochemical characterisation. |
format | Online Article Text |
id | pubmed-8910494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89104942022-03-11 Production of an Active, Human Membrane Protein in Saccharomyces cerevisiae: Full-Length FICD Virolainen, Minttu S. Søltoft, Cecilie L. Pedersen, Per A. Ellgaard, Lars Int J Mol Sci Article The human Fic domain-containing protein (FICD) is a type II endoplasmic reticulum (ER) membrane protein that is important for the maintenance of ER proteostasis. Structural and in vitro biochemical characterisation of FICD AMPylase and deAMPylase activity have been restricted to the soluble ER-luminal domain produced in Escherichia coli. Information about potentially important features, such as structural motifs, modulator binding sites or other regulatory elements, is therefore missing for the approximately 100 N-terminal residues including the transmembrane region of FICD. Expressing and purifying the required quantity and quality of membrane proteins is demanding because of the low yields and poor stability often observed. Here, we produce full-length FICD by combining a Saccharomyces cerevisiae-based platform with green fluorescent protein (GFP) tagging to optimise the conditions for expression, solubilisation and purification. We subsequently employ these conditions to purify milligram quantities of His-tagged FICD per litre of culture, and show that the purified, detergent-solubilised membrane protein is an active deAMPylating enzyme. Our work provides a straightforward methodology for producing not only full-length FICD, but also other membrane proteins in S. cerevisiae for structural and biochemical characterisation. MDPI 2022-02-23 /pmc/articles/PMC8910494/ /pubmed/35269596 http://dx.doi.org/10.3390/ijms23052458 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Virolainen, Minttu S. Søltoft, Cecilie L. Pedersen, Per A. Ellgaard, Lars Production of an Active, Human Membrane Protein in Saccharomyces cerevisiae: Full-Length FICD |
title | Production of an Active, Human Membrane Protein in Saccharomyces cerevisiae: Full-Length FICD |
title_full | Production of an Active, Human Membrane Protein in Saccharomyces cerevisiae: Full-Length FICD |
title_fullStr | Production of an Active, Human Membrane Protein in Saccharomyces cerevisiae: Full-Length FICD |
title_full_unstemmed | Production of an Active, Human Membrane Protein in Saccharomyces cerevisiae: Full-Length FICD |
title_short | Production of an Active, Human Membrane Protein in Saccharomyces cerevisiae: Full-Length FICD |
title_sort | production of an active, human membrane protein in saccharomyces cerevisiae: full-length ficd |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910494/ https://www.ncbi.nlm.nih.gov/pubmed/35269596 http://dx.doi.org/10.3390/ijms23052458 |
work_keys_str_mv | AT virolainenminttus productionofanactivehumanmembraneproteininsaccharomycescerevisiaefulllengthficd AT søltoftceciliel productionofanactivehumanmembraneproteininsaccharomycescerevisiaefulllengthficd AT pedersenpera productionofanactivehumanmembraneproteininsaccharomycescerevisiaefulllengthficd AT ellgaardlars productionofanactivehumanmembraneproteininsaccharomycescerevisiaefulllengthficd |